Teladoc Health annual revenue
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Teladoc Health Revenue Growth & History (TDOC)
Teladoc Health reported $2.53B in revenue for fiscal 2025, a decrease of 1.54% from the previous fiscal year.
View full Teladoc Health company overviewTeladoc Health annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.53B | −$39.6M | −1.54% |
| 2024 | 2024-12-31 | $2.57B | −$32.8M | −1.26% |
| 2023 | 2023-12-31 | $2.60B | $195.6M | +8.13% |
| 2022 | 2022-12-31 | $2.41B | $374.1M | +18.41% |
| 2021 | 2021-12-31 | $2.03B | $938.7M | +85.81% |
| 2020 | 2020-12-31 | $1.09B | $540.7M | +97.71% |
| 2019 | 2019-12-31 | $553.3M | $135.4M | +32.40% |
| 2018 | 2018-12-31 | $417.9M | $184.6M | +79.14% |
| 2017 | 2017-12-31 | $233.3M | $110.1M | +89.42% |
| 2016 | 2016-12-31 | $123.2M | $45.8M | +59.15% |
| 2015 | 2015-12-31 | $77.4M | $33.9M | +77.78% |
| 2014 | 2014-12-31 | $43.5M | $23.6M | +118.67% |
| 2013 | 2013-12-31 | $19.9M | — | — |
Teladoc Health quarterly revenue
Q2.14
Q3.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $606.9M | −$25.0M | −3.95% |
| Q1 2026 | 2026-03-31 | $613.8M | −$15.5M | −2.47% |
| Q4 2025 | 2025-12-31 | $642.3M | $1.8M | +0.28% |
| Q3 2025 | 2025-09-30 | $626.4M | −$14.1M | −2.20% |
| Q2 2025 | 2025-06-30 | $631.9M | −$10.5M | −1.64% |
| Q1 2025 | 2025-03-31 | $629.4M | −$16.8M | −2.59% |
| Q4 2024 | 2024-12-31 | $640.5M | −$20.0M | −3.03% |
| Q3 2024 | 2024-09-30 | $640.5M | −$19.7M | −2.99% |
| Q2 2024 | 2024-06-30 | $642.4M | −$10.0M | −1.53% |
| Q1 2024 | 2024-03-31 | $646.1M | $16.9M | +2.68% |
| Q4 2023 | 2023-12-31 | $660.5M | $22.8M | +3.58% |
| Q3 2023 | 2023-09-30 | $660.2M | $48.8M | +7.99% |
| Q2 2023 | 2023-06-30 | $652.4M | $60.0M | +10.13% |
| Q1 2023 | 2023-03-31 | $629.2M | $63.9M | +11.30% |
| Q4 2022 | 2022-12-31 | $637.7M | $83.5M | +15.06% |
| Q3 2022 | 2022-09-30 | $611.4M | $89.7M | +17.20% |
| Q2 2022 | 2022-06-30 | $592.4M | $89.2M | +17.74% |
| Q1 2022 | 2022-03-31 | $565.4M | $111.7M | +24.62% |
| Q4 2021 | 2021-12-31 | $554.2M | $170.9M | +44.59% |
| Q3 2021 | 2021-09-30 | $521.7M | $232.8M | +80.62% |
| Q2 2021 | 2021-06-30 | $503.1M | $262.1M | +108.75% |
| Q1 2021 | 2021-03-31 | $453.7M | $272.9M | +150.93% |
| Q4 2020 | 2020-12-31 | $383.3M | $226.8M | +144.95% |
| Q3 2020 | 2020-09-30 | $288.8M | $150.8M | +109.33% |
| Q2 2020 | 2020-06-30 | $241.0M | $110.8M | +85.01% |
| Q1 2020 | 2020-03-31 | $180.8M | $52.2M | +40.62% |
| Q4 2019 | 2019-12-31 | $156.5M | $33.7M | +27.50% |
| Q3 2019 | 2019-09-30 | $138.0M | $27.0M | +24.34% |
| Q2 2019 | 2019-06-30 | $130.3M | $35.7M | +37.77% |
| Q1 2019 | 2019-03-31 | $128.6M | $38.9M | +43.43% |
| Q4 2018 | 2018-12-31 | $122.7M | $45.6M | +59.11% |
| Q3 2018 | 2018-09-30 | $111.0M | $42.3M | +61.63% |
| Q2 2018 | 2018-06-30 | $94.6M | $50.0M | +112.06% |
| Q1 2018 | 2018-03-31 | $89.6M | $46.7M | +108.97% |
| Q4 2017 | 2017-12-31 | $77.1M | $39.7M | +106.26% |
| Q3 2017 | 2017-09-30 | $68.7M | $36.3M | +112.01% |
| Q2 2017 | 2017-06-30 | $44.6M | $18.1M | +68.34% |
| Q1 2017 | 2017-03-31 | $42.9M | $16.0M | +59.54% |
| Q4 2016 | 2016-12-31 | $37.4M | $14.8M | +65.19% |
| Q3 2016 | 2016-09-30 | $32.4M | $12.4M | +62.12% |
| Q2 2016 | 2016-06-30 | $26.5M | $8.2M | +44.88% |
| Q1 2016 | 2016-03-31 | $26.9M | $10.4M | +63.08% |
| Q4 2015 | 2015-12-31 | $22.6M | — | — |
| Q3 2015 | 2015-09-30 | $20.0M | $9.1M | +83.15% |
| Q2 2015 | 2015-06-30 | $18.3M | $8.0M | +77.69% |
| Q1 2015 | 2015-03-31 | $16.5M | — | — |
| Q3 2014 | 2014-09-30 | $10.9M | — | — |
| Q2 2014 | 2014-06-30 | $10.3M | — | — |
Teladoc Health revenue growth trends
Over the last five reported fiscal years, revenue grew from $1.09B to $2.53B, a compound annual growth rate of 18.26%. Teladoc Health's latest reported quarter, Q2 2026, generated $606.9M in revenue, a decrease of 3.95% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Teladoc Health source filings ↗